An expanded role for neuroimaging in the evaluation of memory impairment

RS Desikan, MS Rafii, JB Brewer… - American Journal of …, 2013 - Am Soc Neuroradiology
Alzheimer disease affects millions of people worldwide. The neuropathologic process
underlying this disease begins years, if not decades, before the onset of memory decline …

Diagnostic issues in dementia: neuroimaging as a surrogate marker of disease

GW Small - Journal of geriatric psychiatry and neurology, 2006 - journals.sagepub.com
Structural neuroimaging is a routine component of the diagnostic evaluation of dementia that
is used to rule out potential causes of mental impairment, whereas functional imaging can …

Empowering imaging biomarkers of Alzheimer's disease

BA Gutman, Y Wang, I Yanovsky, X Hua, AW Toga… - Neurobiology of …, 2015 - Elsevier
In a previous report, we proposed a method for combining multiple markers of atrophy
caused by Alzheimer's disease into a single atrophy score that is more powerful than any …

Neuroimaging in Alzheimer disease: an evidence-based review

K Kantarci, CR Jack - Neuroimaging Clinics, 2003 - neuroimaging.theclinics.com
Alzheimer disease (AD) is the most common dementing illness. The prevalence of AD
increases with age, and the disease is becoming a significant health problem as the aging …

What does imaging add to the management of Alzheimer's disease?

GW Small - CNS spectrums, 2004 - cambridge.org
The prevalence of Alzheimer's disease (AD) and dementia continues to rise. However, a
significant number of patients are undiagnosed or untreated. Given the complexities of …

Early diagnosis of Alzheimer's disease and mild cognitive impairment: Imaging, biomarkers, and technology

T Buracchio, J Kaye - Generations, 2009 - ingentaconnect.com
The neuropathological changes of Alzheimer's most likely begin years before a clinical
diagnosis of dementia or even mild cognitive impairment. As potential disease-modifying …

Advances in imaging of AD biomarkers could aid early diagnosis

A Chase - Nature Reviews Neurology, 2014 - go.gale.com
The neuropathological effects of Alzheimer disease (AD) can be clearly observed at
autopsy, but identifying diagnostic and prognostic biomarkers in living people is less …

Neuroimaging in dementias

LC de Souza, S Lehéricy, B Dubois… - Current Opinion in …, 2012 - journals.lww.com
The combined use of neuroimaging examinations with clinical, neuropsychological, and
cerebrospinal fluid markers can improve the specificity of the diagnosis of Alzheimer's …

In-vivo brain neuroimaging provides a gateway for integrating biological and clinical biomarkers of Alzheimer's disease

J Cui, V Zufferey, F Kherif - Current opinion in neurology, 2015 - journals.lww.com
The discovery of efficient therapies to prevent the disease or modify the progression of
disease requires a more thorough understanding of the underlying biological processes …

[PDF][PDF] Neuroimaging in dementia: a brief review

D Banerjee, A Muralidharan, ARH Mohammed… - Cureus, 2020 - cureus.com
Dementia is a clinical syndrome that manifests itself with impairment in cognitive functions
owing to various neurodegenerative etiologies causing severe disability in the older …